P3 Health Begin Period Cash Flow Over Time
| PIIIW Stock | USD 0.01 0 11.88% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out P3 Health Performance and P3 Health Correlation. PIIIW |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIIIW will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 11.552 | Quarterly Revenue Growth 0.152 | Return On Assets (0.12) | Return On Equity (0.41) |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIIIW that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Begin Period Cash Flow Analysis
Compare P3 Health Partners and related stocks such as Encompass Health Corp, Pennant Group, and Acadia Healthcare Begin Period Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHC | 15.8 M | 48.4 M | 30.1 M | 132.8 M | 64.5 M | 66.7 M | 61.6 M | 40.5 M | 116.8 M | 133.5 M | 159.6 M | 310.9 M | 120.3 M | 53.4 M | 50.7 M |
| PNTG | 27 K | 27 K | 27 K | 27 K | 27 K | 27 K | 27 K | 30 K | 36 K | 41 K | 402 K | 43 K | 5.2 M | 2.1 M | 1.1 M |
| ACHC | 4.5 M | 8.6 M | 61.1 M | 49.4 M | 4.6 M | 94 M | 11.2 M | 57.1 M | 67.3 M | 50.5 M | 124.2 M | 378.7 M | 133.8 M | 97.6 M | 89.8 M |
| SEM | 247.5 M | 4.4 M | 12 M | 40.1 M | 4.3 M | 3.4 M | 14.4 M | 99 M | 122.5 M | 175.2 M | 335.9 M | 577.1 M | 74.3 M | 97.9 M | 120.3 M |
| ENSG | 14.8 M | 72.1 M | 29.6 M | 40.7 M | 65.8 M | 50.4 M | 41.6 M | 57.7 M | 42.3 M | 31.1 M | 59.2 M | 236.6 M | 262.2 M | 316.3 M | 332.1 M |
| UHS | 14 M | 29.5 M | 41.2 M | 23.5 M | 17.2 M | 32.1 M | 61.2 M | 33.7 M | 167.3 M | 199.7 M | 105.7 M | 1.3 B | 178.9 M | 200.8 M | 210.9 M |
| SGRY | 5.4 M | 5.4 M | 5.4 M | 5.2 M | 13 M | 74.9 M | 57.9 M | 57.9 M | 175.2 M | 184.6 M | 93 M | 318.2 M | 389.9 M | 282.9 M | 152 M |
| OPCH | 1.8 M | 120.8 M | 120.8 M | 62.1 M | 1 M | 740 K | 15.6 M | 9.6 M | 44.4 M | 36.4 M | 67.1 M | 99.3 M | 119.4 M | 294.2 M | 308.9 M |
| AMED | 1.1 M | 120.3 M | 48 M | 14.5 M | 17.3 M | 8 M | 27.5 M | 30.2 M | 86.4 M | 20.2 M | 96.5 M | 83.4 M | 45.8 M | 54.1 M | 35.1 M |
| EHAB | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 34.8 M | 40 M | 8 M | 27.2 M | 21.3 M |
P3 Health Partners and related stocks such as Encompass Health Corp, Pennant Group, and Acadia Healthcare Begin Period Cash Flow description
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.My Equities
My Current Equities and Potential Positions
| P3 Health Partners | PIIIW |
| Classification | Healthcare |
| Location | Illinois; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.0089
Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.